Influence of homocysteine and its major genetic and nutritional determinants on bone mineral density

##plugins.themes.academic_pro.article.main##

Aissam El Maataoui
Kaoutar Idouz
Abdellah El Maghraoui
Selama Nadifi
Zohra Ouzzif

Abstract

Introduction: A potential role of hyperhomocysteinemia in bone metabolism has been considered from the observation of high prevalence of osteoporosis in
subjects with homocystinuria about 50 years ago.

Aim: To examine the association of homocysteine level and its determinants Methylenetetrahydrofolate Reductase [MTHFR] C677T Polymorphism, folates and
vitamin B12 levels with bone mineral density [BMD] and the prevalence of vertebral fractures [VF] on postmenopausal women.

Methods: Through a cross-sectional study, one hundred and twenty-two healthy postmenopausal women gave their informed consent to participate in this study.
Women were recruited through advertisements and mouth to ear between January 2017 and May 2017. One serum tube and one EDTA tube were collected
from fasting patients. Bone mineral density was determined by a Lunar Prodigy® Vision DXA system®. Vertebral fracture [VF] assessment image was inspected
visually by 2 clinicians.

Results: We found that a high level of homocysteine and low vitamin B12 and folate levels are not associated with bone mineral density and are not risk factors for
VF in healthy postmenopausal women. Whereas, the presence of VF was associated with the number of years since menopause and with the osteocalcin levels.

Conclusion: The MTHFR C677T polymorphism, the high levels of HCY, or low levels of folate and vitamin B12 would not be risk factors for osteoporosis and VF
in healthy postmenopausal women.

Keywords:

Homocysteine - Methylenetetrahydrofolate Reductase C677T polymorphism - Bone mineral density - Vertebral Fracture.

##plugins.themes.academic_pro.article.details##

References

  1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. Southern medical journal. 2001 Jun;94(6):569–73. PMID: 11440324.
  2. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, et al. Are effects of MTHFR [C677T] genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone. 2005 Mar;36(3):577– 83. doi: 10.1016/j.bone.2004.12.014. PMID: 15777680.
  3. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, et al. A common methylenetetrahydrofolate reductase [C677T] polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2003 Apr;18(4):723–9. doi: 10.1359/ jbmr.2003.18.4.723. PMID: 12674333
  4. Agueda L, Urreizti R, Bustamante M, Jurado S, Garcia-Giralt N, Díez-Pérez A, et al. Analysis of three functional polymorphisms in relation to osteoporosis phenotypes: replication in a Spanish cohort. Calcified tissue international. 2010 Jul;87(1):14–24. doi: 10.1007/ s00223-010-9361-4. PMID: 20390408
  5. Bahtiri E, Islami H, Rexhepi S, Qorraj-Bytyqi H, Thaçi K, Thaçi S, et al. Relationship of homocysteine levels with lumbar spine and femur neck BMD in postmenopausal women. Acta Reumatologica Portuguesa. 2015;2015(4):355–62. PMID: 26922199
  6. Bozkurt N, Erdem M, Yilmaz E, Erdem A, Biri A, Kubatova A, et al. The relationship of homocyteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Archives of gynecology and obstetrics. 2009 Sep;280(3):381–7. doi: 10.1007/s00404-009-0936-0. Epub 2009 Jan 17. PMID: 19151987.
  7. Cagnacci A, Bagni B, Zini A, Cannoletta M, Generali M, Volpe A. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A fiveyear longitudinal evaluation. Bone. 2008 Feb;42(2):314–20. doi: 10.1016/j.bone.2007.10.022. Epub 2007 Nov 12. PMID: 18289506.
  8. Devoto M. Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Human Molecular Genetics. 2001 Oct 1;10(21):2447– 52. doi: 10.1093/hmg/10.21.2447. PMID: 11689491.
  9. Kuroda T, Tanaka S, Saito M, Shiraki Y, Shiraki M. Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women. Calcified tissue international. 2013 Sep;93(3):269–75. doi: 10.1007/ s00223-013-9754-2. Epub 2013 Jun 21. PMID: 23793599.
  10. Dhonukshe-Rutten RAM, Pluijm SMF, de Groot LCPGM, Lips P, Smit JH, van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2005 Jun;20(6):921–9. doi: 10.1359/JBMR.050202. Epub 2005 Feb 7. PMID: 15883631.
  11. Kanazawa I, Tomita T, Miyazaki S, Ozawa E, Yamamoto LA, Sugimoto T. Bazedoxifene Ameliorates Homocysteine-Induced Apoptosis and Accumulation of Advanced Glycation End Products by Reducing Oxidative Stress in MC3T3-E1 Cells. Calcified tissue international. 2017;100(3):286–97. doi: 10.1007/ s00223-016-0211-x. Epub 2016 Nov 10. PMID: 27832315.
  12. Raposo B, Rodríguez C, Martínez-González J, Badimon L. High levels of homocysteine inhibit lysyl oxidase(LOX(and downregulate LOX expression in vascular endothelial cells. Atherosclerosis. 2004 Nov;177(1):1–8. doi: 10.1016/j. atherosclerosis.2004.06.015. PMID: 15488859.
  13. Kang AH, Trelstad RL. A collagen defect in homocystinuria. The Journal of clinical investigation. 1973 Oct;52(10):2571–8. doi: 10.1172/JCI107449. PMID: 4729050; PMCID: PMC302517
  14. Mclean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a Predictive Factor for Hip Fracture in Older Persons. Vol. 350, N Engl J Med. 2004. doi: 10.1056/NEJMoa032739. PMID: 15141042
  15. Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: A cross-sectional study. Bone. 2004 Sep;35(3):760–5. doi: 10.1016/j.bone.2004.04.018. PMID: 15336613.
  16. Riancho JA, Valero C, Zarrabeitia MT. MTHFR polymorphism and bone mineral density: Meta-analysis of published studies. Calcified Tissue International. 2006 Nov;79(5):289–93. doi: 10.1007/s00223-006- 0143-y. Epub 2006 Nov 14. PMID: 17115239
  17. Li D, Wu J. Association of the MTHFR C677T polymorphism and bone mineral density in postmenopausal women: a meta-analysis. Journal of biomedical research. 2010 Nov;24(6):417–23. doi: 10.1016/S1674-8301(10)60056- 5. PMID: 23554658;
  18. Li M, Lau EMC, Woo J. Methylenetetrahydrofolate reductase polymorphism [MTHFR C677T] and bone mineral density in Chinese men and women. Bone. 2004 Dec;35(6):1369–74. doi: 10.1016/j.bone.2004.09.008. PMID: 15589218.
  19. Shiraki M, Urano T, Kuroda T, Saito M, Tanaka S, Miyao-Koshizuka M, et al. The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures. Journal of bone and mineral metabolism. 2008;26(6):595–602. doi: 10.1007/s00774-008-0878- 9. Epub 2008 Nov 1. PMID: 18979159.
  20. Wang H, Liu C. Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: An updated meta-analysis. Osteoporosis International. 2012;23(11):2625–34. doi: 10.1007/ s00198-011-1885-6. Epub 2011 Dec 21. PMID: 22187009
  21. Li WF, Hou SX, Yu B, Li MM, Férec C, Chen JM. Genetics of osteoporosis: accelerating pace in gene identification and validation. Human genetics. 2010 Mar;127(3):249– 85. doi: 10.1007/s00439-009-0773-z. Epub 2009 Dec 12. PMID: 20101412.